根据该协议,Catalent将向TFF提供其扩大规模的专业知识和制造能力,作为其首选的开发和制造合作伙伴,Catalent将能够向其客户提供TFF技术,这有可能增加...查看全文
美港电讯APP2020-09-24 21:21
TFF制药(TFFP.O):在实验中,发现含亮氨酸的瑞德西韦干粉制剂能更持久地从肺释放到到血浆,公司正与吉利德科学(GILD.O)就此研究结果进行讨论。$TFF Pharmaceuticals(TFFP)$ $吉利德科学(GILD)$ (来自美港电讯APP)查看全文
chuminhua2020-08-14 10:55
8月13日,TFF Pharmaceuticals,Inc.$TFF Pharmaceuticals(TFFP)$ 是一家临床阶段的生物制药公司,专注于根据其专利的薄膜冷冻(TFF)技术平台开发和商业化创新药物产品,宣布已与UNION therapeutics签订了一项全球独家许可协议,将其TFF技术与氯硝柳胺(niclosamide)联合使用。根据协议条款,UNI...查看全文
$TFF Pharmaceuticals(TFFP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-24-035083 Size: 6 KB 网页链接
$TFF Pharmaceuticals(TFFP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-24-035081 Size: 6 KB 网页链接
$TFF Pharmaceuticals(TFFP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-24-035080 Size: 8 KB 网页链接
$TFF Pharmaceuticals(TFFP)$ DEF 14A Other definitive proxy statements Accession Number: 0001213900-24-034929 Act: 34 Size: 1 MB 网页链接
$TFF Pharmaceuticals(TFFP)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001213900-24-034931 Act: 34 Size: 1 MB 网页链接
$TFF Pharmaceuticals(TFFP)$ ARS Annual Report to Security Holders Accession Number: 0001213900-24-034935 Act: 34 Size: 1 MB 网页链接
$TFF Pharmaceuticals(TFFP)$ S-1 General form for registration of securities under the Securities Act of 1933 Accession Number: 0001213900-24-034178 Act: 33 Size: 496 KB 网页链接
$TFF Pharmaceuticals(TFFP)$ S-1 General form for registration of securities under the Securities Act of 1933 Accession Number: 0001213900-24-030971 Act: 33 Size: 619 KB 网页链接
$TFF Pharmaceuticals(TFFP)$ D Notice of Exempt Offering of Securities, item 06b Accession Number: 0001213900-24-029354 Act: 33 Size: 13 KB 网页链接
$TFF Pharmaceuticals(TFFP)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001213900-24-027199 Act: 34 Size: 273 KB 网页链接